The interplay between parasitemia, IL-10, IFN-gamma, and other mediators is important in determining patient outcomes during treatment, particularly in the control of pathological inflammatory responses and in the ultimate acquisition of immunological memory and protective immunity. Here, IL10 is linked to parasitic infectious disease.